Burlingame, CA, United States of America

Nigel Pelham Clinton Walker

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 7.3

ph-index = 9

Forward Citations = 229(Granted Patents)


Location History:

  • Hayward, CA (US) (2023)
  • Burlingame, CA (US) (2013 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Nigel Pelham Clinton Walker

Introduction

Nigel Pelham Clinton Walker is a prominent inventor based in Burlingame, California. With an impressive portfolio consisting of 13 patents, he has significantly contributed to the fields of biotechnology and pharmaceuticals. His innovative work focuses on developing antibodies that target critical pathways in cancer and infectious diseases.

Latest Patents

Among his latest patents, Nigel has made substantial advancements with "Anti-CD39 antibodies and use thereof," which involves antibodies that inhibit the enzymatic activity of human CD39. This innovation holds promise for various therapeutic applications. Another notable patent is "Antibodies to TIGIT," which provides antibodies that bind specifically to TIGIT, allowing for the substantial activation of T cells and natural killer cells by inhibiting the binding of TIGIT to CD155. These antibodies are positioned for use in treating cancer and infectious diseases, showcasing the versatility and importance of his work.

Career Highlights

Throughout his career, Nigel has worked with industry leaders such as Amgen Inc. and Arcus Biosciences, Inc. His experience in these reputable companies has undoubtedly enriched his expertise and practical insights into the biopharmaceutical landscape.

Collaborations

Collaboration has also been a key factor in Nigel's inventiveness. He has had the opportunity to work alongside talented individuals, including Simon Mark Jackson and Derek Evan Piper, whose input and shared knowledge have likely influenced his innovative approaches and success in developing novel therapies.

Conclusion

Nigel Pelham Clinton Walker stands as a testament to the power of innovation in medicine. His contributions to the development of antibodies targeting critical pathways in disease treatment exemplify the impact that dedicated inventors can have on modern healthcare. With his continued work, the future of therapeutic interventions for serious health challenges appears promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…